Weighing the Complexity of Pathologic Response in Lung Cancer

Pathologic response has emerged as a valuable endpoint and surrogate marker for overall survival in lung cancer studies, but much work remains to be done.

Related Keywords

New York ,United States ,Memorial Sloan Kettering Cancer Center ,Williamd Travis , ,Lung Cancer Conference ,Clinical Oncology ,International Association ,Lung Cancer Recommendations ,Pathologic Assessment ,Lung Cancer Resection Specimens After Neoadjuvant ,Lung Cancer ,Ung Carcinoma ,Ancer Lung ,Chemotherapy ,Neoadjuvant ,Non Small Cell Lung Cancer ,Nsclc ,Neoplasm ,Physician Assistants ,Tumor ,Breast Cancer ,Alignant Breast Neoplasm ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Residual Disease ,Thoracic Region Of Chest ,Chest ,